Cough, Cold, Allergic Rhinitis Flashcards
Dextromethorphan: contraindications
(antitussive)
- MAOIs
- CNS depressants (alcohol, benzos)
Benzonatate: MOA
(antitussive)
reduces cough by anesthetizing respiratory passages (eliminates “tickling” sensation which precipitates cough)
Guaifenesin: MOA
(expectorant)
increases hydration of respiratory tract> increases volume and decreases viscosity of secretions
camphor: MOA
(local anesthetic)
- reduces sensitivity to cough receptors in periphery
- anesthetizes throat/local air passageways
note: lethal if ingested
menthol: MOA
(local anesthetic)
- reduces sensitivity to cough receptors in periphery
- anesthetizes throat/local air passageways
benzocaine: MOA
(local anesthetic)
- reduces sensitivity to cough receptors in periphery
- anesthetizes throat/local air passageways
Oral decongestants: contraindications
- uncontrolled HTN
- BPH or urinary retention
- glaucoma
- cardiac disease
- hyperthyroidism
NSAIDS: contraindications
- increased risk GI bleed
- renal dysfunction
- CV disease
- aspirin allergy
Aspirin: contraindications
- Children <19 (Reye’s Syndrome)
- increased risk GI bleed
- gout
- NSAID allergy
Acetaminophen: contraindications
liver dysfunction/damage
Echinachea: contraindications
asthma, allergy to ragweed/chrysanthemum, immunodeficiency, TB, autoimmune disorders
How long do you need to hold antihistamines for before allergen testing?
1st gen: 3-5 days
2nd gen: 10 days
Antihistamines: MOA
- H1 receptor antagonists: inhibit H1 receptor-mediated effects of histamine
- anti-inflammatory effects
1st gen antihistamines: contraindications
use w/ other CNS depressants, elderly pts (anticholinergic effects)
Which 2nd gen antihistamines are most potent and most sedating?
cetirizine & levocetirizine
Oral 2nd gen antihistamines: USPSTF recommendations
- AR w/ primary complains of sneezing/itching
- mild AR, intermittent symptoms
What are key differences between 1st and 2nd generation antihistamines?
-1st gen= more lipophilic» more crossing BBB, more sedating, more anticholinergic, dose more often
Intranasal Steroids: USPSTF recommendation
moderate, severe SAR or PAR; symptoms affecting QOL
Intranasal steroids: MOA
- anti-inflammatory: reduce release of inflammatory cells within nasal mucosa
- reduce hyperresponsiveness of nasal mucosa to subsequent exposures to allergen
Intranasal Steroids: concerning ADR
- growth suppression in children
- ^ IOP
- HPA axis disruption
AR: Pathophysiology
Exposure to allergen: -Type I hypersensitivity -IgE antibody production Subsequent exposure: -IgE antibodies attach to mast cells -Release histamines/leukotrienes -Early phase rxn Late-phase rxn: -Histamines & leukotrienes call more inflammatory cells to area -Nasal congestion and postnasal drip 48hrs
Describe best use of decongestants for AR.
short-term adjunctive/secondary therapy for severe congestion while an intranasal steroid is onboarded
-no effect on sneezing/itching/ocular symptoms
Describe best use of leukotriene receptor antagonists for AR.
- adjunctive/secondary therapy
- asthma + allergic rhinitis*
- decongestion
Mast cell stabilizers: MOA
- bind to mast cells and prevent release of inflammatory mediators
- effect w/ early & late phase AR